Current Treatment Landscape of Advanced Papillary Renal Cancer

J Clin Oncol. 2017 Sep 10;35(26):2981-2983. doi: 10.1200/JCO.2017.74.3328. Epub 2017 Jul 24.

Authors

Brian Shuch¹, Andrew W Hahn¹, Neeraj Agarwal¹

Affiliation

¹ Brian Shuch, Yale School of Medicine, New Haven, CT; Andrew W. Hahn, University of Utah School of Medicine, Salt Lake City, UT; and Neeraj Agarwal, University of Utah School of Medicine and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT.

PMID: 28737973
DOI: 10.1200/JCO.2017.74.3328

No abstract available

Publication types

Editorial
Comment

MeSH terms

Biomarkers
Carcinoma, Renal Cell*
Humans
Kidney Neoplasms*
Pyrazines
Triazines

Substances

Biomarkers
Pyrazines
Triazines
1-(1-(imidazo(1,2-a)pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-(1,2,3)triazolo(4,5-b)pyrazine